Jami A. Kinnucan, M.D.

  1. Gastroenterologist
  2. Women's Health Specialist
  1. Dunlay SM, Sangaralingham LR, Lampman MA, Ziegelbauer LL, Smith JL, Kall MM, Kinnucan JA, Farris KJ, Mattson JL, Storino CB, Loftus CG. Implementation of Billing for Patient Portal Messages as E-visits in a Large Integrated Health System. Ann Intern Med. 2025 Jan; 178 (1):11-19 Epub 2024 Dec 31
    View PubMed
  2. Odah T, Karime C, Hashash JG, Kinnucan JA, Picco MF, Farraye FA. The Utility of Patency Capsule in Patients With Crohn's Disease. J Clin Gastroenterol. 2024 Oct 15 [Epub ahead of print]
    View PubMed
  3. Karime C, Black CN, Cortes P, Kwon JY, Caldera F, Crosby SK, Picco MF, Kinnucan JA, Hashash JG, Farraye FA. Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination. Am J Gastroenterol. 2024 Oct 1; 119 (10):2079-2085 Epub 2024 May 08
    View PubMed
  4. Odah T, Karime C, Desai A, Picco MF, Kinnucan JA, Hashash JG, Farraye FA. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib. Dig Dis Sci. 2024 Oct; 69 (10):3911-3919 Epub 2024 Sept 09
    View PubMed
  5. Nieto LM, Bezabih Y, Narvaez SI, Rouse C, Perry C, Vega KJ, Kinnucan J. Single center assessment of the role of Oakland score among patients admitted for acute lower gastrointestinal bleeding. BMC Gastroenterol. 2024 Jul 15; 24 (1):225 Epub 2024 July 15
    View PubMed
  6. Petrov JC, Desai AA, Kochhar GS, Crosby SK, Kinnucan JA, Picco MF, Hashash JG, Farraye FA. Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study. Inflamm Bowel Dis. 2024 Jul 12 Epub 2024 July 12
    View PubMed
  7. Siu RK, Karime C, Hashash JG, Kinnucan J, Picco MF, Farraye FA. Sirolimus Use in Refractory Crohn's Disease. ACG Case Rep J. 2024 Jun; 11 (6):e01368 Epub 2024 June 14
    View PubMed
  8. Siu RK, Karime C, Hashash JG, Kinnucan J, Picco MF, Farraye FA. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease. Crohns Colitis 360. 2024 Jan; 6(1):otae007. Epub 2024 Jan 24.
    View PubMed
  9. Almujarkesh MK, Alsakarneh S, Almeqdadi M, Al Ta'ani O, Mohamad B, Kinnucan J. The effect of the coronavirus (covid-19) pandemic on gender and medical school diversity in gastroenterology fellowship matching. Gastro Hep Advances. 2024; 3 (5):654-8
  10. Loeb L, Nasir A, Picco MF, Hashash JG, Kinnucan JA, Farraye FA. Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease. Inflamm Bowel Dis 2023 Sep 1; 29 (9):e37
    View PubMed
  11. Scott FI, Ehrlich O, Wood D, Viator C, Rains C, DiMartino L, McArdle J, Adams G, Barkoff L, Caudle J, Cheng J, Kinnucan J, Persley K, Sariego J, Shah S, Heller C, Rubin DT. Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation. Inflamm Bowel Dis. 2023 Aug 1; 29 (8):1177-1190
    View PubMed
  12. Bali AS, Hashash JG, Picco MF, Kinnucan JA, Farraye FA. Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and Training. Am J Gastroenterol. 2023 Jul 1; 118 (7):1282-1284 Epub 2023 Mar 20
    View PubMed
  13. Loftus EV, Baumgart DC, Gecse K, Kinnucan JA, Connelly SB, Salese L, Su C, Kwok KK, Woolcott JC, Armuzzi A. Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program. Inflamm Bowel Dis. 2023 May 2; 29 (5):744-751
    View PubMed
  14. Nieto LM, Salazar M, Kinnucan J, Lukens FJ, Argueta PP. Incidence, Burden, and Predictors of Readmission for Acute Alcoholic Pancreatitis: A National Analysis over 11 Months. Dig Dis Sci. 2023 Feb; 68 (2):423-433 Epub 2022 Dec 24
    View PubMed
  15. Dubinsky MC, Magro F, Steinwurz F, Hudesman DP, Kinnucan JA, Ungaro RC, Neurath MF, Kulisek N, Paulissen J, Su C, Ponce de Leon D, Regueiro M. Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program. Inflamm Bowel Dis. 2023 Jan 5; 29 (1):51-61
    View PubMed
  16. Jordan A, Kinnucan J. Ustekinumab-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn's Disease. ACG Case Rep J. 2022 Oct; 9 (10):e00867 Epub 2022 Oct 06
    View PubMed
  17. Jordan A, Maraj B, Kinnucan J. Is it a Flare? Acute Appendicitis in Ulcerative Colitis Patient Found on Routine Screening Colonoscopy. Inflamm Bowel Dis. 2022 Sep 1; 28 (9):1472-1473
    View PubMed
  18. Chaisidhivej N, Maneerattanaporn M, Pongpaibul A, Trongtorsak A, Kinnucan J. Cronkhite-Canada Syndrome: A Rare Case of Chronic Diarrhea With Ectodermal Changes. Cureus. 2022 Sep; 14 (9):e29298 Epub 2022 Sept 18
    View PubMed
  19. Nieto LM, Narvaez SI, Asthana A, Mohammed A, Kinnucan J. Transient Neurogenic Bowel Dysfunction in a Case of Cocaine-Induced Spinal Cord Infarction. Cureus. 2022 Apr; 14 (4):e23834 Epub 2022 Apr 05
    View PubMed
  20. Berinstein JA, Sheehan JL, Dias M, Berinstein EM, Steiner CA, Johnson LA, Regal RE, Allen JI, Cushing KC, Stidham RW, Bishu S, Kinnucan JAR, Cohen-Mekelburg SA, Waljee AK, Higgins PDR. Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study. Clin Gastroenterol Hepatol. 2021 Oct; 19 (10):2112-2120.e1 Epub 2021 May 25
    View PubMed
  21. Abou-Hanna JJ, Owens ST, Kinnucan JA, Mian SI, Kolars JC. Resuscitating the Socratic Method: Student and Faculty Perspectives on Posing Probing Questions During Clinical Teaching. Acad Med. 2021 Jan 1; 96 (1):113-117
    View PubMed
  22. Cohen BL, Gallinger ZR, Ha C, Holubar SD, Hou JK, Kinnucan J, Mahadevan U, Moss AC, Raffals LE, Regueiro M, Szigethy E, Wolf D, Dubinsky MC, Patel A, Shah BJ, Ehrlich OG, Hanauer SB. Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States. Inflamm Bowel Dis. 2020 Aug 20; 26 (9):1291-1305
    View PubMed
  23. Spencer EA, Kinnucan J, Wang J, Dubinsky MC. Real-World Experience With Acute Infusion Reactions to Ustekinumab at 2 Large Tertiary Care Centers. Crohn's and Colitis 360. 2020; 2(2):otaa022.
  24. Riehl ME, Kinnucan JA, Chey WD, Stidham RW. Nuances of the psychogastroenterology patient: A predictive model for gastrointestinal quality of life improvement. Neurogastroenterol Motil. 2019 Sep; 31 (9):e13663 Epub 2019 June 17
    View PubMed
  25. Bishu S, El Zaatari M, Hayashi A, Hou G, Bowers N, Kinnucan J, Manoogian B, Muza-Moons M, Zhang M, Grasberger H, Bourque C, Zou W, Higgins PDR, Spence JR, Stidham RW, Kamada N, Kao JY. CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor alpha in Active Crohn's Disease. J Crohns Colitis. 2019 Jul 25; 13 (7):905-915
    View PubMed
  26. Kinnucan J, Binion D, Cross R, Evans E, Harlen K, Matarese L, Mullins A, O'Neal B, Reiss M, Scott FI, Weaver A, Rosenberg J. Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology. 2019 Jul; 157 (1):242-254.e6 Epub 2019 Apr 10
    View PubMed
  27. Berinstein JA, Steiner CA, Regal RE, Allen JI, Kinnucan JAR, Stidham RW, Waljee AK, Bishu S, Aldrich LB, Higgins PDR. Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019 Apr; 17 (5):988-990.e1 Epub 2018 Nov 17
    View PubMed
  28. Swaminath A, Berlin EP, Cheifetz A, Hoffenberg E, Kinnucan J, Wingate L, Buchanan S, Zmeter N, Rubin DT. The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information. Inflamm Bowel Dis. 2019 Feb 21; 25 (3):427-435
    View PubMed
  29. Kinnucan J. Use of Medical Cannabis in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2018 Oct; 14 (10):598-601
    View PubMed
  30. Christensen B, Micic D, Gibson PR, Yarur A, Bellaguarda E, Corsello P, Gaetano JN, Kinnucan J, Rao VL, Reddy S, Singh S, Pekow J, Rubin DT. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47 (6):753-762 Epub 2018 Jan 29
    View PubMed
  31. Kinnucan J, Tomal J, Rubin DT. U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis. Inflamm Bowel Dis. 2015 Sep; 21 (9):2154-7
    View PubMed
  32. Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013 Dec; 11 (12):1601-8.e1-4 Epub 2013 July 17
    View PubMed
  33. Kinnucan JA, Rubin DT, Ali T. Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol Hepatol (N Y). 2013 Nov; 9 (11):718-27
    View PubMed
  34. Gawron AJ, Rothe J, Fought AJ, Fareeduddin A, Toto E, Boris L, Kahrilas PJ, Pandolfino JE. Many patients continue using proton pump inhibitors after negative results from tests for reflux disease. Clin Gastroenterol Hepatol. 2012 Jun; 10 (6):620-5; quiz e57 Epub 2012 Feb 22
    View PubMed
  35. Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011 Jan; 140 (1):82-90 Epub 2010 Sept 19
    View PubMed
  36. Rubin DT, Rothe JA. The peri-appendiceal red patch in ulcerative colitis: review of the University of Chicago experience. Dig Dis Sci. 2010 Dec; 55 (12):3495-501 Epub 2010 Oct 09
    View PubMed
  37. Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis. 2010 Aug; 16(8):1352-6.
    View PubMed
  38. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007 Jun; 65 (7):998-1004 Epub 2007 Apr 23
    View PubMed